PERTH, WA, July 2024

ArthroLase Secures $479,251 Innovation Grant to advance Bone-Sparing Orthopaedic Implant Technology

ArthroLase is pleased to announce the award of a $479,251 innovation grant from the Western Australian Government's Future Health Research and Innovation (FHRI) program. This funding will support the development of our AIRO-x™ technology, a next-generation bone-sparing orthopaedic implant that is paired with Arthrolase’s robotic-assisted laser bone shaping technology. The implant is designed to preserve a patient’s heathy bone, and enhance the bond between a patient’s bone and their new implant.

The AIRO-x™ implant transforms the interface between bone and implant with carefully designed curves and ridges that guide the implant into the optimal position. Laser-shaped complex geometric anchoring features maximise the surface area for a secure, long-term bond. This patented design allows for maximum osseointegration between the implant and the bone while targeting and removing only the diseased bone with laser precision.

The award of this grant underscores ArthroLase's important role in Western Australia's medical manufacturing landscape. With this financial support, ArthroLase aims to further develop its intelligent robotic-assisted laser joint resurfacing solutions, advancing health innovation.

The Future Health Research and Innovation Fund is an important and stable source of funding for health and medical research, innovation, and commercialisation. The Fund's support of ArthroLase provides the company with an opportunity to expand its medical manufacturing initiatives, reinforcing Western Australia's status as an innovative hub in the Asia-Pacific region.